Effects of the Herbal Medicine Inchinko-to on Liver Function in Postoperative Patients with Biliary Atresia - A Pilot Study

Journal of Pediatric Surgery

Volumn 38, Issue 11, 2003, Pages 1607-1611

  Iinuma, Yasushi ^a   Kubota, Masayuki ^a   Yagi, Minoru ^a   Kanada, Satoshi ^a   Yamazaki, Satoru ^a   Kinoshita, Yoshiaki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Biliary atresia; Inchinko to; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HERBACEOUS AGENT; HYALURONIC ACID; INCHINKO TO; LIVER ENZYME; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME BLOOD LEVEL; HUMAN; JAUNDICE; LIVER FIBROSIS; LIVER FUNCTION; LIVER PROTECTION; PILOT STUDY; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0242440814     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(03)00570-0     Document Type: Article

References (25)

1. Ohi R, Nio M, Hayashi Y, et al: Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg 25:442-445, 1990
2. Kobayashi H, Horikoshi K, Yamataka A, et al: Are stable post-operative biliary atresia patients really stable? Pediatr Surg Int 17:104-107, 2001
3. Altman RP, Lilly JR, Greenfeld J, et al: A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia. Ann Surg 226:348-355, 1997
4. Kobayashi H, Horikoshi K, Yamataka A, et al: Hyaluronic acid: A specific prognostic indicator of hepatic damage in biliary atresia. J Pediatr Surg 34:1791-1794, 1999
5. Hasegawa T, Sasaki T, Kimura T, et al: Measurement serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia. J Pediatr Surg 35:1643-1646, 2000
6. Kiso Y, Ogasawara Y, Hirota K, et al: Antihepatotoxic principles of Artemisia capillaries buds. Planta Medica 1:81-85234, 1984
7. Takeda S, Endo T, Aburada M: Pharmacological studies on iridoid compounds. The choleretic mechanism of iridoid compounds. J Pharm Dyn 4:612-623, 1981
8. Okuno I, Uchida K, Nakamura M, et al: Studies on choleretic constituents in Artemisia capillaries THUMB. Chem Pharmacol Bull 36:769-775, 1988
9. Yamamoto M, Ogawa K, Morita M, et al: The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor β1. Hepatology 23:552-559, 1996
10. Yamasahiki M, Mase A, Arai I, et al: Effect of the Japanese herbal medicine Inchinko-to (TJ-135) on concanavalin A-induced hepatitis in mice. Clin Sci 99:421-431, 2000
11. Inao M, Mochida S, Matui A, et al: Efficacy of Inchin-ko-to (TJ-135), ajapanese herbal medicine, in the treatment of liver chirrhosis, as evaluated rat models. Hepatology 34:298(abstr), 2001
12. Onji M, Kikuchi T, Michitaka K, et al: Combined use of ursodeoxycholic acid and inchin-ko-to in jaundice patients with primary biliary cirrhosis. [abstract in English]. J Med Pharm Soc Wakan-Yaku 7:161-167, 1990
13. Sakaguchi Y, Mizoguchi Y, Seki M, et al: Effect of Intinko-to treatment on intrahepatic cholestasis and acute severe hepatitis [abstract in English]. J Med Pharm Soc Wakan-Yaku 4:124-129, 1987
14. Kasai M, Sawaguchi S, Akiyama H, et al: A proposal of new classification of biliary atresia. J Jpn Soc Pediatr Surg 12:327-331, 1976
15. Takeda S, Iizuka A, Funo S, et al: Effect of Chinese prescription "Inchinko-to" on experimental hepatobiliary injury induced by α-naphtylisothiocyanate [abstract in English]. J Med Pharm Soc Wakan-Yaku 1:230-234, 1984
16. Ihara N, Arichi S: Protective effect of oriental crude drugs a kampo medicine on a fuluminant type of galactosamine-induced hepatitis [abstract in English]. Proc Symp Wakan-Yaku 14:45-55, 1981
17. Kiso Y, Suzuki Y, Konno C, et al: Application of carbon tetrachrolide-induced liver lesion in mice for screening of liver protective crude drugs. Shoyakugaku Zasshi 36:238-244, 1982
18. Howard ER, Maclean M, Nio M, et al: Survival patterns in biliary atresia and comparison of quality of life long-term survivors in Japan and England. J Pediatr Surg 36:892-897, 2001
19. Yamamoto M, Miura N, Ohtake N, et al: Genipin, a metabolic derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology 118:380-389, 2000
20. Nakamura T, Sakata R, Ueno T, et al: Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethinitrosoamine-treated rats. Hepatology 32:247-255, 2000
21. Ramm GA, Nair VG, Bridle KR, et al: Contribution of hepatic parenchymal and non parenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 153:527-535, 1998
22. Trivedi P, Cheeseman P, Mowat AP: Serum hyaluronic acid in healthy infants and children and its value as a marker of progressive hepatobiliary disease in infancy. Clin Chim Acta 215:29-39, 1993
23. Kobayashi H, Horikoshi K, Yamataka A, et al: Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients. Pediatr Surg Int 17:386-389, 2001
24. Loebstein R, Vohra S, Koren G: Drug therapy in pediatric patients, in Carruthers SG et al (eds): Melon and Morrelli's Clinical Pharmacology ed. 4. McGraw Hill, 2000, pp 1143-1149
25. Ishizaki T, Sasaki F, Ameshima S, et al: Pneumonia during interferon and/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J 9:2691-2696, 1996